158 related articles for article (PubMed ID: 30264250)
1. ASO Author Reflections: Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma.
Yoh T; Seo S
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):780-781. PubMed ID: 30264250
[No Abstract] [Full Text] [Related]
2. Proposal of a New Preoperative Prognostic Model for Solitary Hepatocellular Carcinoma Incorporating
Yoh T; Seo S; Ogiso S; Kawai T; Okuda Y; Ishii T; Taura K; Higashi T; Nakamoto Y; Hatano E; Kaido T; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):542-549. PubMed ID: 29168098
[TBL] [Abstract][Full Text] [Related]
3. Low Utility of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Detecting Hepatocellular Carcinoma in Patients Before Liver Transplantation.
Alotaibi F; Kabbani M; Abaalkhail F; Chorley A; Elbeshbeshy H; Al-Hamoudi W; Alabbad S; Boehnert MU; Alsofayan M; Al-Kattan W; Ahmed B; Broering D; Al Sebayel M; Elsiesy H
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):37-41. PubMed ID: 28260429
[TBL] [Abstract][Full Text] [Related]
4. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of
Lee SM; Kim HS; Lee S; Lee JW
World J Gastroenterol; 2019 Mar; 25(11):1289-1306. PubMed ID: 30918424
[TBL] [Abstract][Full Text] [Related]
6. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET and hepatocellular carcinoma.
Kashiwagi T
J Gastroenterol; 2004 Oct; 39(10):1017-8. PubMed ID: 15549460
[No Abstract] [Full Text] [Related]
8. 18F-Fluorodeoxyglucose positron emission tomography for monitoring response to sorafenib treatment in patients with hepatocellular carcinoma.
Siemerink EJ; Mulder NH; Brouwers AH; Hospers GA
Oncologist; 2008 Jun; 13(6):734-5; author reply 736-7. PubMed ID: 18586929
[No Abstract] [Full Text] [Related]
9. Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
Hong G; Suh KS; Suh SW; Yoo T; Kim H; Park MS; Choi Y; Paeng JC; Yi NJ; Lee KW
J Hepatol; 2016 Apr; 64(4):852-9. PubMed ID: 26658686
[TBL] [Abstract][Full Text] [Related]
10. ASO Author Reflections: mLST8 is a Prognostic Biomarker and Involved in Tumor Progression in Hepatocellular Carcinoma.
Yu XN; Shen XZ; Guo HY; Zhu JM
Ann Surg Oncol; 2020 May; 27(5):1558-1559. PubMed ID: 32166592
[No Abstract] [Full Text] [Related]
11. Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee SD; Kim SH; Kim SK; Kim YK; Park SJ
Transplantation; 2015 Oct; 99(10):2142-9. PubMed ID: 25905981
[TBL] [Abstract][Full Text] [Related]
12. FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy.
Kurtovic J; Van Der Wall H; Riordan SM
Clin Nucl Med; 2005 Jun; 30(6):408-10. PubMed ID: 15891293
[No Abstract] [Full Text] [Related]
13. [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
Kong YH; Han CJ; Lee SD; Sohn WS; Kim MJ; Ki SS; Kim J; Jeong SH; Kim YC; Lee JO; Cheon GJ; Choi CW; Lim SM
Korean J Hepatol; 2004 Dec; 10(4):279-87. PubMed ID: 15613803
[TBL] [Abstract][Full Text] [Related]
14. Important factors determining prognosis based on SUVmax in PET imaging.
Şahin E; Akcan AB
Turk J Gastroenterol; 2015 Sep; 26(5):442. PubMed ID: 26215070
[No Abstract] [Full Text] [Related]
15. Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection.
Hatano E; Ikai I; Higashi T; Teramukai S; Torizuka T; Saga T; Fujii H; Shimahara Y
World J Surg; 2006 Sep; 30(9):1736-41. PubMed ID: 16850145
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
Hyun SH; Eo JS; Lee JW; Choi JY; Lee KH; Na SJ; Hong IK; Oh JK; Chung YA; Song BI; Kim TS; Kim KS; Moon DH; Yun M
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1638-45. PubMed ID: 26936852
[TBL] [Abstract][Full Text] [Related]
17. ASO Author Reflections: Liver Transplantation for Hepatocellular Carcinoma.
Wong TCL; Ng KKC
Ann Surg Oncol; 2019 May; 26(5):1463-1464. PubMed ID: 30684160
[No Abstract] [Full Text] [Related]
18. A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
Ahn SG; Jeon TJ; Lee SD; Kim SH; Cho HJ; Yun M; Park YN; Lee JD; Park SJ; Kim KS
Eur J Surg Oncol; 2013 Sep; 39(9):964-73. PubMed ID: 23859893
[TBL] [Abstract][Full Text] [Related]
19. [Value of (18)F-FDG PET in preoperative TACE of hepatocellular carcinoma].
Chang Z; Song P; Wang M; Liu F; Duan F; Wang Z; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):377-81. PubMed ID: 25030595
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid hepatocellular carcinoma diagnosed by FDG PET/CT.
Mi B; Wan W; Yu C; You X; Xu Q
Clin Nucl Med; 2011 Oct; 36(10):925-7. PubMed ID: 21892049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
